98 related articles for article (PubMed ID: 24156129)
21. Long-term results of radiochemotherapy for solitary lymph node metastasis after curative resection of esophageal cancer.
Jingu K; Ariga H; Nemoto K; Narazaki K; Umezawa R; Takeda K; Koto M; Sugawara T; Kubozono M; Miyata G; Onodera K; Yamada S
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):172-7. PubMed ID: 22079727
[TBL] [Abstract][Full Text] [Related]
22. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer.
Miyata H; Yamasaki M; Takiguchi S; Nakajima K; Fujiwara Y; Nishida T; Mori M; Doki Y
J Surg Oncol; 2009 Nov; 100(6):442-6. PubMed ID: 19653262
[TBL] [Abstract][Full Text] [Related]
23. Indications and outcome of salvage surgery for oesophageal cancer.
D'Journo XB; Michelet P; Dahan L; Doddoli C; Seitz JF; Giudicelli R; Fuentes PA; Thomas PA
Eur J Cardiothorac Surg; 2008 Jun; 33(6):1117-23. PubMed ID: 18342532
[TBL] [Abstract][Full Text] [Related]
24. [Perioperative management and prevention of complication for salvage esophagectomy after definitive chemoradiotherapy].
Kamei T; Miyazaki S
Kyobu Geka; 2008 Jul; 61(8 Suppl):731-7. PubMed ID: 20715419
[TBL] [Abstract][Full Text] [Related]
25. [Chemoradiotherapy].
Muro K
Nihon Geka Gakkai Zasshi; 2008 Jan; 109(1):15-20. PubMed ID: 18320805
[TBL] [Abstract][Full Text] [Related]
26. Factors affecting the prognosis of patients with esophageal cancer undergoing salvage surgery after definitive chemoradiotherapy.
Tomimaru Y; Yano M; Takachi K; Miyashiro I; Ishihara R; Nishiyama K; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
J Surg Oncol; 2006 Apr; 93(5):422-8. PubMed ID: 16550581
[TBL] [Abstract][Full Text] [Related]
27. Nonoperable patients with superficial esophageal cancer treated by photodynamic therapy after chemoradiotherapy have more severe complications than patients treated in primary intent.
Lecleire S; Di Fiore F; Antonietti M; Ben-Soussan E; Hochain P; Lerebours E; Michel P; Ducrotté P
Am J Gastroenterol; 2008 Sep; 103(9):2215-9. PubMed ID: 18844614
[TBL] [Abstract][Full Text] [Related]
28. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma.
Kato K; Nakajima TE; Ito Y; Katada C; Ishiyama H; Tokunaga SY; Tanaka M; Hironaka S; Hashimoto T; Ura T; Kodaira T; Yoshimura K
Jpn J Clin Oncol; 2013 Jun; 43(6):608-15. PubMed ID: 23585687
[TBL] [Abstract][Full Text] [Related]
29. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906).
Kato K; Muro K; Minashi K; Ohtsu A; Ishikura S; Boku N; Takiuchi H; Komatsu Y; Miyata Y; Fukuda H;
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):684-90. PubMed ID: 20932658
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of chemoradiotherapy and surgical resection for cT4 esophageal cancer.
Morita M; Toh Y; Saeki H; Sugiyama M; Ohgaki K; Maehara S; Minami K; Ikeda Y; Sakaguchi Y; Okamura T; Uehara S; Maehara Y
Anticancer Res; 2012 Aug; 32(8):3275-82. PubMed ID: 22843902
[TBL] [Abstract][Full Text] [Related]
31. [A multi-centered randomized controlled study of neo-adjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of esophagus: an interim analysis].
YANG H; FU JH; LIU MZ; FANG WT; WANG JM; CHEN YP; CHEN ZJ; XIANG JQ; YANG HJ; MAO WM; ZHENG X; ZHU CC; KONG M; HAN YT; LI T
Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(15):1028-32. PubMed ID: 22781642
[TBL] [Abstract][Full Text] [Related]
32. [Effectiveness and safety of chemoradiation in a community-based population of patients with esophageal cancer].
Goto A; Hasegawa Y; Sukawa Y; Fujii K; Matunaga Y; Suzuki K; Yonezawa K; Abe T; Wakasugi H; Itoh M; Itoh A; Shinomura Y; Kagei K
Gan To Kagaku Ryoho; 2010 Nov; 37(11):2115-9. PubMed ID: 21084810
[TBL] [Abstract][Full Text] [Related]
33. [Therapeutic strategy for marginally resectable esophageal cancer].
Koyanagi K; Ozawa S
Gan To Kagaku Ryoho; 2011 Aug; 38(8):1241-5. PubMed ID: 21829059
[TBL] [Abstract][Full Text] [Related]
34. [Chemoradiotherapy followed by surgery in treatment of locally advanced esophageal carcinoma: a phase II trial].
Fu JH; Rong TH; Li XD; Hu Y; Ou W; Hu YH; Li Q
Ai Zheng; 2004 Nov; 23(11 Suppl):1473-6. PubMed ID: 15566661
[TBL] [Abstract][Full Text] [Related]
35. [Salvage surgery for the T4 esophageal cancer following downstaging by neoadjuvant chemoradiotherapy].
Ando N; Ozawa S; Kitagawa Y; Takeuchi H; Kitajima M
Nihon Geka Gakkai Zasshi; 1997 Sep; 98(9):767-72. PubMed ID: 9370137
[TBL] [Abstract][Full Text] [Related]
36. [A case of effective photodynamic therapy for local recurrence after definitive chemoradiotherapy for esophageal cancer].
Kiyotoki S; Nishikawa J; Tanimoto H; Saito M; Hamabe K; Okamoto T; Noguchi T; Sakaida I
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2055-7. PubMed ID: 20037321
[TBL] [Abstract][Full Text] [Related]
37. [A case of advanced esophageal cancer invaded to the trachea with PCR after preoperative chemoradiotherapy, which relapsed at the time of three years and seven months after resection].
Kawasaki H; Wajima N; Miyamoto K; Maruyama A; Takahashi K; Kubo N; Hakamada K
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2388-90. PubMed ID: 22202391
[TBL] [Abstract][Full Text] [Related]
38. Surgery after primary chemoradiotherapy in squamous cancer of the esophagus: is the photon mightier than the sword?
Ilson DH
J Clin Oncol; 2007 Apr; 25(10):1155-6. PubMed ID: 17401002
[No Abstract] [Full Text] [Related]
39. [Multivariate prognostic analysis for patients with unresectable esophageal carcinoma after concurrent chemoradiotherapy].
Chen EC; Liu MZ; Hu YH; Li QQ; Liu H; Cai L; Liu H; Lin HX; Huang Y; Wang HY; Cui NJ
Ai Zheng; 2005 Jun; 24(6):731-4. PubMed ID: 15946490
[TBL] [Abstract][Full Text] [Related]
40. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
